FdaApplication
NDA 213972
Identifiers
- fda_app_no: NDA213972
Properties
| Property | Value |
|---|---|
| applicant_name | ITERUM THERAPEUTICS US LTD |
| application_type | NDA |
| approval_date | 2024-10-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORLYNVAH | PROBENECID; SULOPENEM ETZADROXIL | 500MG;500MG | TABLET;ORAL |
1 product